Friday, October 30 2026

Haleon Pakistan starts local manufacturing of Panadol 500mg tablets in Sindh
Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has commenced manufacturing Panadol 500mg tablets at its Jamshoro facility, marking a shift towards in-house production of the popular pain relief medicine. The company, which is primarily engaged in the manufacturing, marketing, and sale of consumer healthcare and over-the-counter (OTC) health products, disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Friday.
Related news categories: business economic-indicators pharma psx stock-exchanges
Related symbols: haleon (news stock)